Results 201 to 210 of about 128,736 (321)

Graves’ hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA

, 2003
Jeffrey C. Flynn, Prakash Rao, Monika Góra, Ghazwan Alsharabi, Wenjing Wei, Alvaro A. Giraldo, Chella S. David, J. Paul Banga, Yi‐chi M. Kong   +8 more
openalex   +1 more source

New‐onset autoimmune disease following SARS‐CoV‐2 infection and mRNA vaccination in Norway: A retrospective cohort study

Journal of Internal Medicine, Volume 299, Issue 2, Page 271-282, February 2026.
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås, Paz Lopez‐Doriga Ruiz, Jesper Dahl, Hanne L. Gulseth, German Tapia   +4 more
wiley   +1 more source

Subclinical Hyperthyroidism and the Cardiovascular Disease

Hormone and Metabolic Research, 2017
A. Delitala
semanticscholar   +1 more source

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon   +15 more
wiley   +1 more source

The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

, 1984
N. R. Peden, Ian R. Hart
openalex   +1 more source

Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study.

European Journal of Endocrinology, 2016
M. Søgaard, D. Farkas, V. Ehrenstein, J. Jørgensen, O. Dekkers, H. Sørensen   +5 more
semanticscholar   +1 more source

Increased risk of hyperthyroidism induced by immune checkpoint inhibitors in patients with existing or prior Graves' disease: a nested prospective cohort study with propensity score matching. [PDF]

Front Endocrinol (Lausanne)
Suzuki K, Kobayashi T, Izuchi T, Murase T, Ando M, Handa T, Onoue T, Miyata T, Sugiyama M, Hagiwara D, Suga H, Banno R, Arima H, Iwama S.   +13 more
europepmc   +1 more source

The effects of iodinated contrast media exposure on thyroid functions after angiography in patients with subclinical hyperthyroidism: a retrospective study. [PDF]

Thyroid Res
Demirbaş ZE, Can F.
europepmc   +1 more source

Mendelian randomization analysis: causal link between hyperthyroidism/thyrotoxicosis and ovarian cancer. [PDF]

Discov Oncol
Wang H, Liang C, Yu Y, Lin J, Dong Y, Hong X, Huang H.   +6 more
europepmc   +1 more source

Graves' disease with autoimmune hepatitis and primary Sclerosing cholangitis: an overlap syndrome. [PDF]

Oxf Med Case Reports
Pragathi LK, Gandhi D, Tetarbe S, Chandrashekhar SR, Shah I.   +4 more
europepmc   +1 more source